Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
Clinical trial NCT01650350 · TERMINATED
Trial details
- NCT number
- NCT01650350
- Sponsor
- Brown University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-10-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.